“…In addition, retinal degeneration is also reported in other neurodegenerative diseases, traditionally affecting other CNS regions, such as multiple sclerosis (including in the absence of associated optic neuritis) [ 106 , 107 , 108 ], Alzheimer’s [ 109 , 110 ], and Parkinson’s [ 111 , 112 ], diseases, giving rise to the concept that the retina can serve as ‘diagnostic window into the brain’ and giving insight into neurodegenerative processes occurring elsewhere [ 113 ]. In humans, thinning of the retinal nerve fibre layer (RNFL) containing RGC axons has been used as a diagnostic indicator of retinal, and particularly RGC, degeneration (as well as testing of neuroprotective therapies) since this region is particularly vulnerable in glaucoma [ 114 ], diabetic retinopathy [ 115 ], retinal ischemia [ 116 ] and in optic neuritis [ 104 ] as well as in multiple sclerosis [ 117 ], Alzheimer’s [ 118 , 119 ] and Parkinson’s [ 120 , 121 ] diseases.…”